Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma

详细信息    查看全文

• 作者：Beatriz Samara de Brito^a (MD Student) ; Natá ; lia Giovanelli^a (MD Student) ; Erika Said Egal ; DVM^a ; Celeste Sá ; nchez-Romero ; DDS ; MSc^b ; Juliana de Souza do Nascimento ; DDS ; MsC^b ; Antonio Santos Martins ; MD ; PhD^c ; Á ; lfio José ; Tincani ; MD ; PhD^c ; André ; Del Negro ; MD ; PhD^c ; Rogé ; rio de Oliveira Gondak ; DDS ; PhD^d ; Oslei Paes de Almeida ; DDS ; PhD^b ; Luiz Paulo Kowalski ; MD ; PhD^e ; Albina Altemani ; MD ; PhD^a ; Fernanda Viviane Mariano ; DDS ; PhD^a ; ^{fevimariano@gmail.com" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Pleomorphic adenoma ; Carcinoma ex pleomorphic adenoma ; PLAG1 ; Immunohistochemistry ; Malignant transformation ; Carcinogenesis
• 刊名：Human Pathology
• 出版年：2016
• 出版时间：November 2016
• 年：2016
• 卷：57
• 期：Complete
• 页码：152-159
• 全文大小：2039 K

文摘

PLAG1 (pleomorphic adenoma gene 1) is frequently activated in pleomorphic adenoma (PA). Carcinoma ex pleomorphic adenoma (CXPA) arises in PA, and PLAG1 expression is believed to be maintained from PA to CXPA, as it can contribute to the carcinogenesis process. To evaluate if PLAG1 is a good marker of malignant transformation from PA to CXPA as well as to evaluate if PLAG1 expression is associated with progression and histopathologic subtype of CXPA. Forty PAs, 21 residual PAs (without malignant transformation), and 40 CXPAs were analyzed by immunohistochemistry with PLAG1 antibody. The proportion of positive neoplastic cells was assessed according to a 2-tiered scale: >10% to 50%, and >50% positive cells. The CXPA group was classified according to histopathologic subtype and invasiveness degree. Thirty-seven PAs (92.5%), 15 residual PAs (71%), and 14 CXPAs (35%) were positive for PLAG1. In relation to the CXPA group, among the intracapsular cases, myoepithelial carcinoma and epithelial-myoepithelial carcinoma showed the highest level of PLAG1 expression. PLAG1 expression is lost when PA undergoes malignant transformation, possibly due to other pathway activation and different clone cells. In addition, PLAG1 expression seems to be present mainly in low-grade carcinomas and in cases with early phase of invasion, due to its regulation of oncogene-induced cell senescence. In CXPA, PLAG1 expression was most associated with myoepithelial differentiation. This way, loss of PLAG1 expression can be considered a hallmark of CXPA carcinogenesis, mainly when there is only epithelial differentiation.